Table 1.
Study | Year | Total: Size of classes | Accuracy |
---|---|---|---|
Shen et al.83 | 2010 | 52: 32 SCZ, 20 HC | 86.50% |
Fan et al.84 | 2011 | 62: 31 SCZ, 31 HC | 87.1%a |
Yu et al.85 | 2013 | 89: 32 SCZ, 38 HC (+19 MDD) | 80.9% |
Anderson and Cohen86 | 2013 | 146: 74 SCZ, 72 HC (COBRE dataset) | 65% |
Arbabshirani et al.87 | 2013 | 56: 28 SCZ, 28 HC | 96%a |
Yu et al.88 | 2013 | 71: 24 SCZ, 25 healthy siblings of SCZ, 22 HC | 62% |
Guo et al.89 | 2014 | 131: 69 SCZ, 62 HC | 80% |
Brodersen et al.90 | 2014 | 83: 41 SCZ, 42 HC | 78%a |
Anticevic et al.91 | 2014 | 180: 90 SCZ, 90 HC | 73.9% |
Watanabe et al.92 | 2014 | 123: 54 SCZ, 67 HC | 73.50% |
Chyzhyk et al.93 | 2015 | 54: 26 SCZ with history of AH, 14 SCZ without a history of AH, 28 HC | 97.1%a |
Cheng et al.94 | 2015 | 48: 19 SCZ, 29 HC | 79% |
Peters et al.95 | 2016 | 36: 18 SCZ, 18 HC | 91%a |
Mikolas et al.96 | 2016 | 126: 63 SCZ with FE SCZ, 63 HC | 73% |
Cabral et al.34 | 2016 | 132: 66 SCZ, 66 HC (COBRE dataset) | 70.5% |
Yang et al.97 | 2016 | 86: 40 SCZ, 46 HC | 77.91% |
Iwabuchi and Palaniyappan98 | 2017 | 133: 62 SCZ, 71 HC | 78.04%a |
Lottman et al.99 | 2017 | 69: 34 unmedicated (17 drug-naive) SCZ + follow-up post treatment, 35 HC | 83.8%a |
Guo et al.100 | 2017 | 68: 28 FE drug-naive SCZ, 28 family-based controls, 40 HC | 92.86%a |
SCZ Schizophrenia, HC Healthy controls, AH Auditory hallucinations, FE First episode, MDD Major depression
aAccuracy of best model among several reported models